G Anker Selected Research

Therapeutics

4/2007	Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.
5/2001	High-dose estrogen treatment in postmenopausal breast cancer patients heavily exposed to endocrine therapy.
10/2000	Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial. Scandinavian Breast Group 9401 study.
5/2000	High activity and tolerability demonstrated for exemestane in postmenopausal women with metastatic breast cancer who had previously failed on tamoxifen treatment.
1/2000	[Population-related findings and treatment results and clinic variations in the Munich field study of rectal carcinoma].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

G Anker Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 04/2007 - 05/2000
1	Neoplasms (Cancer) 05/2001
1	Disease Progression 05/2000
1	Rectal Neoplasms (Rectal Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2007 - 10/2000
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2007 - 10/2000
2	Fluorouracil (Carac)FDA LinkGeneric 04/2007 - 10/2000
2	Carboplatin (JM8)FDA LinkGeneric 04/2007 - 10/2000
2	Tamoxifen FDA LinkGeneric 04/2007 - 05/2000
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 04/2007 - 10/2000
2	Epirubicin (Ellence)FDA LinkGeneric 04/2007 - 10/2000
1	Estrogens (Estrogen)FDA Link 05/2001
1	Diethylstilbestrol (Stilbestrol)FDA Link 05/2001
1	exemestane (Aromasin)FDA Link 05/2000

Therapy/Procedure

5	Therapeutics 04/2007 - 01/2000
1	Radiotherapy 04/2007
1	Drug Therapy (Chemotherapy) 10/2000